Strength Training and Testosterone Treatment Have Opposing Effects on Migration Inhibitor Factor Levels in Ageing Men
Table 1
Baseline data.
Placebo ()
TT ()
ST ()
Age (years)
67 (65–70)
68 (62–72)
68 (62–73)
MIF (pg/mL)
203 (128–378)
182 (117–453)
259 (199–498)
MCP-1 (pg/mL)
71 (59–86)
72 (63–105)
87 (64–101)
MIP-1α (pg/mL)
27 (13–1981)
17 (9–1257)
29 (11–1764)
BioT (nmol/L)
4.4 (3.3–6.0)
5.1 (4.3–6.1)
5.3 (2.2–6.2)
LBM (kg)
64.7 (58.5–73.3)
64.6 (57.2–71.3)
65.4 (60.2–72.0)
Waist (cm)
105 (98–118)
107 (103–115)
107 (104–115)
Fat mass (kg)
23.9 (18.2–33.1)
24.3 (21.4–31.8)
25.2 (22.5–28.7)
Central fat mass (kg)
13.1 (9.0–18.4)
14.0 (12.5–18.2)
14.7 (12.3–17.4)
SAT
24.2 (21.5–34.9)
29.3 (24.5–40.7)
27.9 (24.6–33.1)
VAT
15.6 (11.5–20.0)
15.1 (12.4–19.3)
16.5 (12.3–19.3)
Data presented as median (interquartile range). Baseline data from the subgroups ST + placebo and ST + TT can be seen in Table 2. No significant differences, Mann-Whitney test between groups. BioT: bioavailable testosterone. LBM: lean body mass. SAT: subcutaneous adipose tissue. VAT: visceral adipose tissue.
